IP Library Granted Patent US 9,050,206
Granted Patent B2
US 9,050,206 · App. 13/796,031 · Granted Jun 9, 2015

Vascular stenting for aneurysms

Inventors: Aaron L. Berez (Menlo Park, CA); Quang Q. Tran (Redwood City, CA)
Assignee: Covidien LP
A61F2/95A61F2002/9534A61F2/86A61B17/12118A61B2017/12054A61B17/12022A61B17/12109A61B2017/00867A61B2017/1205A61B2017/22001A61F2/01A61F2/013A61F2/82A61F2/852A61F2/90A61F2/915A61F2/958A61F2/966A61F2002/016A61F2002/018A61F2002/823A61F2002/826A61F2002/91558A61F2002/9505A61F2002/9522A61F2002/9528A61F2002/9665A61F2230/0069A61F2230/0078A61F2230/008A61F2250/0015A61F2250/0063A61F2/07A61F2230/001A61F2230/0091A61F2230/0095
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,050,206
App. No.
13/796,031
Granted
Jun 9, 2015
Kind
B2
Abstract

Described herein are flexible implantable occluding devices that can, for example, navigate the tortuous vessels of the neurovasculature. The occluding devices can also conform to the shape of the tortuous vessels of the vasculature. In some embodiments, the occluding devices can direct blood flow within a vessel away from an aneurysm or limit blood flow to the aneurysm. Some embodiments describe methods and apparatus for adjusting, along a length of the device, the porosity of the occluding device. In some embodiments, the occluding devices allows adequate blood flow to be provided to adjacent structures such that those structures, whether they are branch vessels or oxygen-demanding tissues, are not deprived of the necessary blood flow.

Claims (28)

1. A method, of treating an aneurysm in a vessel of a patient, comprising:

expanding, in the vessel, a first stent;

expanding, at least partially within the first stent, a second stent; and

applying an axially compressive force to a first portion of either the first stent or the second stent, the first portion overlying the aneurysm, whereby the first portion transitions from a first porosity to a second porosity, less than the first porosity, while (i) the first portion maintains a substantially constant cross-sectional dimension and (ii) wherein movement of a second portion of either the first stent or the second stent, distal to the first portion, is impeded by a frictional force applied by either the first stent or the second stent distal to the aneurysm.

2. The method of claim 1 , wherein blood flow through the first and second stents into the aneurysm is less than blood flow into the aneurysm would be through the first stent alone.

3. The method of claim 1 , wherein the first stent and the second stent have, when unrestrained, substantially the same porosity.

4. The method of claim 1 , wherein either the first stent or the second stent has, when unrestrained, a porosity between about 60% and about 85%.

5. The method of claim 1 , wherein the axially compressive force is applied by an elongate member.

6. The method of claim 5 , wherein the elongate member is a lattice density adjusting implement.

7. A method, of treating an aneurysm in a vessel of a patient, comprising:

expanding, in the vessel, a first stent;

applying an axially compressive force to a first portion of the first stent, the first portion overlying the aneurysm, whereby the first portion transitions from a first porosity to a second porosity, less than the first porosity, while (i) the first portion maintains a substantially constant cross-sectional dimension and (ii) wherein movement of a second portion of the first stent, distal to the first portion, is impeded by a frictional force applied by the first stent against a wall of the vessel distal to the aneurysm; and

expanding, at least partially within the first stent, a second stent.

8. The method of claim 7 , wherein blood flow through the first and second stents into the aneurysm is less than blood flow into the aneurysm would be through the first stent alone.

9. The method of claim 7 , wherein the first stent and the second stent have, when unrestrained, substantially the same porosity.

10. The method of claim 7 , wherein either the first stent or the second stent has, when unrestrained, a porosity between about 60% and about 85%.

11. The method of claim 7 , wherein the axially compressive force is applied by an elongate member.

12. The method of claim 11 , wherein the elongate member is a lattice density adjusting implement.

13. A method, of treating an aneurysm in a vessel of a patient, comprising:

expanding, in the vessel having the aneurysm and a branch vessel, a first stent, such that at least a portion of the first stent overlies the aneurysm and the branch vessel;

expanding, at least partially within the first stent, a second stent; and

applying an axially expansive force to a first portion of either the first stent or the second stent, the first portion overlying the branch vessel, whereby the first portion transitions from a first porosity to a second porosity, greater than the first porosity, while (i) the first portion maintains a substantially constant cross-sectional dimension and (ii) wherein movement of a second portion of either the first stent or the second stent, distal to the first portion, is impeded by a frictional force applied by either the first stent or the second stent distal to the branch vessel.

14. The method of claim 13 , wherein at least a portion of the second stent overlies the aneurysm.

15. The method of claim 14 , wherein blood flow through the first and second stents into the aneurysm is less than blood flow into the aneurysm would be through the first stent alone.

16. The method of claim 13 , wherein the first stent and the second stent have, when unrestrained, substantially the same porosity.

17. The method of claim 13 , wherein either the first stent or the second stent has, when unrestrained, a porosity between about 60% and about 85%.

18. The method of claim 13 , wherein the axially expansive force is applied by an elongate member.

19. The method of claim 18 , wherein the elongate member is a lattice density adjusting implement.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2019
From: BEREZ, AARON LEE; TRAN, QUANG QUOC
To: CHESTNUT MEDICAL TECHNOLOGIES, INC.
Reel/Frame 050641/0380 →
MERGER Recorded Oct 7, 2019
From: CHESTNUT MEDICAL TECHNOLOGIES, INC.
To: EV3 INC.
Reel/Frame 050641/0415 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2019
From: EV3 LLC
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 050641/0553 →
CHANGE OF NAME Recorded Oct 7, 2019
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 050647/0135 →
CHANGE OF NAME Recorded Oct 7, 2019
From: EV3 INC.
To: EV3 LLC
Reel/Frame 050647/0179 →
Continuity (9)
Continuation 12431716 · Apr 28, 2009
Continuation In Part 11136395 · May 25, 2005
Continuation In Part 11136398 · May 25, 2005
Continuation In Part 11420025 · May 24, 2006
Continuation In Part 11136395 · May 25, 2005
Continuation In Part 11420027 · May 24, 2006
Continuation In Part 11420023 · May 24, 2006
Provisional Application 60574429 · May 25, 2004
Related Publication 20140094896A1 · Apr 3, 2014